The Singapore National Breast Screening Programme: Principles and implementation

Annals of the Academy of Medicine Singapore

Volumn 32, Issue 4, 2003, Pages 466-476

  Wang, Shih Chang ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Breast cancer detection; Breast cancer in Asian women; Implementation; Screening mammography

Indexed keywords

ADULT; AGE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MORTALITY; NEEDLE BIOPSY; REVIEW; RISK FACTOR; SINGAPORE;

EID: 0141843461     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Chia K S, Seow A, Lee H P, Shanmugaratnam K. Cancer incidence in Singapore 1993-1997: breast cancer. Singapore: Singapore Cancer Registry, 2000. Report No. 5.
2. Chia K S, Lee J J, Wong J L, Gao W, Lee H P, Shanmugaratnam K. Cancer incidence in Singapore, 1998 to 1999. Ann Acad Med Singapore 2002; 31:745-50.
3. Parkin D M, Whelan S L, Ferlay J, Raymond L, Young J M, editors. Cancer incidence in five continents Vol VII. Vol. 143. Lyon: IARC Scientific Publications, 1997.
4. National Cancer Institute Surveillance, Epidemiology and End-Results. Cancer Statistics. 2003. (Accessed I February 2003, at http://www.seer.cancer.gov/statistics/index.html.)
5. Gaudette L A, Silberberger C, Altmayer C A, Gao R N. Trends in breast cancer incidence and mortality. Health Rep 1996; 8:29-37.
6. Australian Institute of Women's Health. Breast cancer in Australian women 1982-1996 (AIHW Cancer Series). Canberra: Australasian Association of Cancer Registries & NHMRC National Breast Cancer Centre, 1999.
7. Chang A Y C, Chow L W C, Chen S C. Breast cancer - an Asian perspective. 2000. (Accessed 3 February 2003, at http://www.scientific-com.com/oncology/vol4.2/conference_report.)
8. Azhar T, Kasule Sr O H, al-Mashor S H, Ngoh H L, Zain Z M, Lim G, et al. Cancer incidence in Malaysia. Int Med Bull 2002; 1: page nos?.
9. Yoo K Y, Kang D, Park S K, Kim S U, Shin A, Yoon H, et al. Epidemiology of breast cancer in Korea: occurrence, high-risk groups, and prevention. J Korean Med Sci 2002; 17:1-6.
10. Kricker A, Jelfs P. Breast cancer in Australian women 1921-1994. Sydney: Commonwealth of Australia, 1996. (Accessed at http://www.nbcc.org.au/pages/info/resource/nbccpubs/bc21-94/contents.htm.)
11. Ng E H, Ng F C, Tan P H, Low S C, Chiang G, Tan K P, et al. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project. Cancer 1998; 82:1521-8.
12. Thomas D B, Gao D L, Ray R M, Wang W W, Allison C J, Chen F L, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002; 94:1445-57.
13. nd ed. Philadelphia: Lippincott-Raven, 1998:107-16.
14. Rickard M, Donnellan M. Diagnosis of small sized invasive breast cancer by an Australian mammography screening service: surrogate end-points for mortality reduction. Aust N Z J Surg 1998; 68:415-8.
15. Narod S A. On being the right size: a reappraisal of mammography trials in Canada and Sweden. Lancet 1997; 349:1846.
16. Tabar L, Vitak B, Chen H H, Prevost T C, Duffy S W. Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results. Swiss Surg 1999; 5:199-204.
17. Alexander F E, Anderson T J, Brown H K, Forrest A P, Hepburn W, Kirkpatrick A E, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999; 353:1903-8.
18. Frisell J, Lidbrink E, Hellstrom L, Rutqvist L E. Follow-up after 11 years - update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997; 45:263-70.
19. UK Trial of Early Detection of Breast Cancer. 16-year mortality from breast cancer. Lancet 1999; 353:1909-14.
20. Larsson L G, Nystrom L, Wall S, Rutqvist L, Andersson I, Bjurstam N, et al. The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer-related excess mortality. J Med Screen 1996; 3:129-32.
21. Nystrom L, Larsson L G, Wall S, Rutqvist L E, Andersson I, Bjurstam N, et al. An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts. J Med Screen 1996; 3:85-7.
22. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355:129-34.
23. Baum M. Rethink on screening for breast cancer. Lancet 1997; 350: 810-1.
24. Baum M. NHS breast screening programme. Money may be better spent on symptomatic women. BMJ 1999; 318:398.
25. Baum M. Screening for breast cancer, time to think - and stop? Lancet 1995; 346:436-7; discussion 439.
26. Baum M. Screening mammography re-evaluated. Lancet 2000; 355: 751-2.
27. Leung G M, Lam T H, Hedley A J. Screening mammography re-evaluated. Lancet 2000; 355:751-2.
28. de Koning H J. Screening for breast cancer, time to think - and stop? Lancet 1995; 346:438-9.
29. Cates C, Senn S. Screening mammography re-evaluated. Lancet 2000; 355:750, 752.
30. Duffy S W, Tabar L. Screening mammography re-evaluated. Lancet 2000; 355:747-8, 752.
31. Hayes C, Fitzpatrick P, Daly L, Buttimer J. Screening mammography re-evaluated. Lancet 2000; 355:749, 752.
32. Law M, Hackshaw A, Wald N. Screening mammography re-evaluated. Lancet 2000; 355:749-50, 752.
33. Miller A B, Baines C J, To T, Wall C. Screening mammography re-evaluated. Lancet 2000; 355:747, 752.
34. Moss S, Blanks R, Quinn M J. Screening mammography re-evaluated. Lancet 2000; 355:748, 752.
35. Nystrom L. Screening mammography re-evaluated. Lancet 2000; 355:748-9, 752.
36. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist L E. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002; 359:909-19.
37. Goel V, Cohen M M, Kaufert P, MacWilliam L. Assessing the extent of contamination in the Canadian National Breast Screening Study. Am J Prev Med 1998; 15:206-11.
38. Demissie K, Mills O F, Rhoads G G. Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography. J Clin Epidemiol 1998; 51:81-91.
39. Tabar L, Vitak B, Chen H H, Yen M F, Duffy S W, Smith R A. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001; 91: 1724-31.
40. Game J P, Aspegren K, Balldin G, Ranstam J. Increasing incidence of and declining mortality from breast carcinoma. Trends in Malmo, Sweden, 1961-1992. Cancer 1997; 79:69-74.
41. Leung G M, Lam T H, Thach T Q, Hedley A J. Will screening mammography in the East do more harm than good? Am J Public Health 2002; 92:1841-6.
42. Chan L K, Lam H S, Chan E S, Lau Y, Chan M, Gwi E, et al. Mammogram screening of Chinese women in Kwong Wah Hospital, Hong Kong. Australas Radiol 1998; 42:6-9.
43. Kopans D B. Screening for breast cancer. In: Kopans D B, editor. Breast Imaging. 2nd ed. Philadelphia: Lippincott-Raven, 1998:55-100.
44. The Essendon Breast X-ray Program Collaborative Group. A mammographic screening pilot project in Victoria 1988-1990. Med J Aust 1992; 157:670-3.
45. Robinson J I, Crane C E, King J M, Scarce D I, Hoffmann C E. The South Australian Breast X-Ray Service: results from a statewide mammographic screening programme. Br J Cancer 1996; 73:837-42.
46. Larsson L G, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabar L, et al. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization. J Natl Cancer Inst Monogr 1997; 22:57-61.
47. Jansen J T, Zoetelief J. Assessment of lifetime gained as a result of mammographic breast cancer screening using a computer model. Br J Radiol 1997; 70:619-28.
48. Moss M. Spotting breast cancer: doctors are weak link. The New York Times 2002 June 27.
49. Laming D, Warren R. Improving the detection of cancer in the screening of mammograms. J Med Screen 2000; 7:24-30.
50. Blanks R G, Wallis M G, Moss S M. A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one- and two-view mammography: results from the UK National Health Service breast screening programme. J Med Screen 1998; 5:195-201.
51. Thurfjell E. Mammography screening methods and diagnostic results. Acta Radiol Suppl 1995; 395:1-22.
52. Gao F, Chia K S, Ng F C, Ng E H, Machin D. Interval cancers following breast cancer screening in Singaporean women. Int J Cancer 2002; 101:475-9.
53. Everington D, Gilbert F J, Tyack C, Warner J. The Scottish breast screening programme's experience of monitoring interval cancers. J Med Screen 1999; 6:21-7.
54. Fielder H, Rogers C, Gower-Thomas K, Monypenny I, Dallimore N, Brook D, et al. Results from 10 years of breast screening in Wales. J Med Screen 2001; 8:21-3.
55. Fracheboud J, de Koning H J, Beemsterboer P M, Boer R, Verbeek A L, Hendriks J H, et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 1999; 81:912-7.
56. de Rijke J M, Schouten L J, Schreutelkamp J L, Jochem I, Verbeek A L. A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, the Netherlands. J Med Screen 2000; 7:19-23.
57. Johnson A E, Shekhdar J. Interval cancers in the National Health Service Breast Screening Programme. Br J Radiol 1995; 68:862-9.
58. Tabar L, Fagerberg G, Duffy S W, Day N E, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992; 30:187-210.
59. Lidbrink E K, Tornberg S A, Azavedo E M, Frisell J O, Hjalmar M L, Leifland K S, et al. The general mammography screening program in Stockholm. Organisation and first-round results. Acta Oncol 1994; 33:353-8.
60. Clover K, Redman S, Forbes J, Sanson-Fisher R, Callaghan T. Two sequential randomized trials of community participation to recruit women for mammographic screening. Prev Med 1996; 25:126-34.
61. Majeed F A, Cook D G, Given-Wilson R, Vecchi P, Poloniecki J. Do general practitioners influence the uptake of breast cancer screening? J Med Screen 1995; 2:119-24.
62. Vizcaino I, Gadea L, Andreo L, Salas D, Ruiz-Perales F, Cuevas D, et al. Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography. Radiology 2001; 219:475-83.
63. National Cancer Institute Surveillance, Epidemiology and End-Results. Breast cancer incidence and mortality data 2002. (Accessed 3 February 2003, at http://seer.cancer.gov/faststats/.)
64. Orel S G, Kay N, Reynolds C, Sullivan D C. BI-RADS categorization as a predictor of malignancy. Radiology 1999; 211:845-50.